The impact of biotechnology on developing countries

Survey results on the influence of genetically modified organisms - several warnings on genetically modified organisms (GMO) and their research

Environmental, economic, healthy and social impacts (usually) are controversial and it is difficult to decide the conclusion.

Long-term (environmental and other) impacts of GMOs in real life are not well evaluated in cross-border comparisons, large-scale research.

The economic impact of genetically modified organisms usually involves various (different) factors and it is difficult to evaluate because it is difficult to "separate" them from the influence of GMO. Results are usually case sensitive

Discussions have vested interests. The choice of pro / anti-GMO is inherently related to a wide selection of controversial agriculture and development models.

For beneficial effects on the development of genetically modified organisms, small-scale farmers that are particularly beneficial to developing countries are necessary.

2011: 16 billion hectares of GM crops in 29 countries, half of developing countries

Two main features: insecticidal GM crops (BT, corn, cotton only) and herbicide tolerance (HT, all four)

Regulatory framework on intellectual property / seed exchange, institutional support for farmers, regulatory supervision of GM usage, prospect of public sector research

Policy significance There is no strong reason to promote GMO in development cooperation. In other words, a project aimed at promoting GMO should not be a priority for EU development cooperation. For example, organic agriculture including small farmers, capacity building etc.

Invest in public sector research to help developing countries not produce soybeans, cotton, canola, but traditional staple food like the CGIAR Association, but rather home-based food

The EU should not prohibit the enactment of intellectual property laws in developing countries, or farmers to exchange seeds or cultivate their varieties.

Ecology Institute, Pfalzburger Str. 43 - 44, D - 10717 Berlin Telephone. +49 (30) 86880-0, Fax + 49 (30) 86880-100

The second ethical question of social justice is the impact on developing countries' biotechnology in food and agriculture. In this respect, organizations such as the World Bank, FAO, the International Agricultural Research Council, the Rockefeller Foundation, and the international development agencies of developed countries are discussing the "green revolution" agricultural development policy. Here biotechnology is inevitably included in existing discussion. For those who support the actions of ODA, it is claimed that developing countries must adopt agricultural production techniques under the guidance of developed countries. As mentioned above, some people think that the benefits of increased food production outweigh the short-term reversal of individual farmers.

Biotechnology is part of today's scientific development. Promoting research in this field even in developed countries and some developing countries Biotechnology has great commercial potential, in particular to bring revolutionary change to the pharmaceutical industry. The emergence of many biotechnology companies around the world clearly reflects this revolution. Some of these biotechnology companies are Monsanto (USA), Genentech (USA), E Release Miscline, High Bright USA etc. In India there are many companies that succeeded in manufacturing modern biotechnology products, especially pharmaceuticals, and India companies include Pennetia Biotech Ltd., Wipro, Reliance etc.